Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson’s Disease

Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson’s Disease

Background: Levodopa (L-Dopa), representing the therapeutic gold standard for the treatment of Parkinson disease (PD), is associated with side effects like L-Dopa induced dyskinesia (LID). Although several non-genetic and genetic factors have been investigated for association with LID risk, contrast...

Full description

Bibliographic Details
Main Authors: Alfonsina Tirozzi, Nicola Modugno, Nicole Piera Palomba, Rosangela Ferese, Alessia Lombardi, Enrica Olivola, Alessandro Gialluisi, Teresa Esposito
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
SNCA
α-synuclein
levodopa induced dyskinesia
Parkinson disease
rs356219
D4S3481
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.640603/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.640603/full

Similar Items